The Utilization of Cytologic Fine-Needle Aspirates of Lung Cancer for Molecular Diagnostic Testing

In this era of precision medicine, our understanding and knowledge of the molecular landscape associated with lung cancer pathogenesis continues to evolve. This information is being increasingly exploited to treat advanced stage lung cancer patients with tailored, targeted therapy. During the manage...

Full description

Bibliographic Details
Main Author: Michael H. Roh
Format: Article
Language:English
Published: Korean Society of Pathologists & the Korean Society for Cytopathology 2015-07-01
Series:Journal of Pathology and Translational Medicine
Subjects:
Online Access:http://www.jpatholtm.org/upload/pdf/jptm-49-4-300.pdf
id doaj-eab23b2d9cdc4a099e522fd6c53fd30a
record_format Article
spelling doaj-eab23b2d9cdc4a099e522fd6c53fd30a2020-11-24T21:01:41ZengKorean Society of Pathologists & the Korean Society for CytopathologyJournal of Pathology and Translational Medicine2383-78372383-78452015-07-0149430030910.4132/jptm.2015.06.1616530The Utilization of Cytologic Fine-Needle Aspirates of Lung Cancer for Molecular Diagnostic TestingMichael H. RohIn this era of precision medicine, our understanding and knowledge of the molecular landscape associated with lung cancer pathogenesis continues to evolve. This information is being increasingly exploited to treat advanced stage lung cancer patients with tailored, targeted therapy. During the management of these patients, minimally invasive procedures to obtain samples for tissue diagnoses are desirable. Cytologic fine-needle aspirates are often utilized for this purpose and are important not only for rendering diagnoses to subtype patients’ lung cancers, but also for ascertaining molecular diagnostic information for treatment purposes. Thus, cytologic fine-needle aspirates must be utilized and triaged judiciously to achieve both objectives. In this review, strategies in utilizing fine-needle aspirates will be discussed in the context of our current understanding of the clinically actionable molecular aberrations underlying non-small cell lung cancer and the molecular assays applied to these samples in order to obtain treatment-relevant molecular diagnostic information.http://www.jpatholtm.org/upload/pdf/jptm-49-4-300.pdfLung neoplasmsCytologyBiopsy, fine-needleMolecular testingPrecision medicine
collection DOAJ
language English
format Article
sources DOAJ
author Michael H. Roh
spellingShingle Michael H. Roh
The Utilization of Cytologic Fine-Needle Aspirates of Lung Cancer for Molecular Diagnostic Testing
Journal of Pathology and Translational Medicine
Lung neoplasms
Cytology
Biopsy, fine-needle
Molecular testing
Precision medicine
author_facet Michael H. Roh
author_sort Michael H. Roh
title The Utilization of Cytologic Fine-Needle Aspirates of Lung Cancer for Molecular Diagnostic Testing
title_short The Utilization of Cytologic Fine-Needle Aspirates of Lung Cancer for Molecular Diagnostic Testing
title_full The Utilization of Cytologic Fine-Needle Aspirates of Lung Cancer for Molecular Diagnostic Testing
title_fullStr The Utilization of Cytologic Fine-Needle Aspirates of Lung Cancer for Molecular Diagnostic Testing
title_full_unstemmed The Utilization of Cytologic Fine-Needle Aspirates of Lung Cancer for Molecular Diagnostic Testing
title_sort utilization of cytologic fine-needle aspirates of lung cancer for molecular diagnostic testing
publisher Korean Society of Pathologists & the Korean Society for Cytopathology
series Journal of Pathology and Translational Medicine
issn 2383-7837
2383-7845
publishDate 2015-07-01
description In this era of precision medicine, our understanding and knowledge of the molecular landscape associated with lung cancer pathogenesis continues to evolve. This information is being increasingly exploited to treat advanced stage lung cancer patients with tailored, targeted therapy. During the management of these patients, minimally invasive procedures to obtain samples for tissue diagnoses are desirable. Cytologic fine-needle aspirates are often utilized for this purpose and are important not only for rendering diagnoses to subtype patients’ lung cancers, but also for ascertaining molecular diagnostic information for treatment purposes. Thus, cytologic fine-needle aspirates must be utilized and triaged judiciously to achieve both objectives. In this review, strategies in utilizing fine-needle aspirates will be discussed in the context of our current understanding of the clinically actionable molecular aberrations underlying non-small cell lung cancer and the molecular assays applied to these samples in order to obtain treatment-relevant molecular diagnostic information.
topic Lung neoplasms
Cytology
Biopsy, fine-needle
Molecular testing
Precision medicine
url http://www.jpatholtm.org/upload/pdf/jptm-49-4-300.pdf
work_keys_str_mv AT michaelhroh theutilizationofcytologicfineneedleaspiratesoflungcancerformoleculardiagnostictesting
AT michaelhroh utilizationofcytologicfineneedleaspiratesoflungcancerformoleculardiagnostictesting
_version_ 1716777212303114240